10/21/24 |
Novo Nordisk (NVO) |
Rybelsus for Diabetes Mellitus, Type II |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/21/24 |
Novo Nordisk (NVO) |
Rybelsus for Cardiovascular Disease |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/17/24 |
Merck (MRK) |
Clesrovimab for Respiratory Syncytial Virus (RSV) Prevention |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/17/24 |
Supernus Pharmaceuticals (SUPN) |
SPN-820 for Major Depressive Disorder (MDD) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/16/24 |
Merck (MRK) |
Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) |
Subscribers Only |
Subscribers Only |
Subscribers Only |